Circulating nociceptin and CGRP in medication‐overuse headache
- 20 November 2018
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 139 (3) , 269-275
Abstract
Background Previous studies found low serum levels of nociceptin in migraine patients but high serum levels of calcitonin gene‐related peptide (CGRP). CGRP can elicit migraine‐like headache. Medication‐Overuse Headache (MOH) often has migraine features and can mimic chronic migraine. We therefore hypothesized that as in migraine, serum levels of nociceptin would be lower and CGRP serum levels higher in MOH patients compared with those in healthy volunteers. We hypothesized the serum levels would normalize after detoxification. Methods Seventeen MOH patients, hereof 70.6% with chronic migraine and MOH, and 30 sex and age matched headache‐free controls were included. MOH patients underwent a 2‐month out‐patient detoxification program and after six months 10 patients and 19 controls were retested. Blood samples were analyzed blinded. Results We found no differences in the levels of nociceptin and CGRP between MOH patients and controls (p=0.65 and p=0.59). The mean headache frequency reduction was 43% and 70% of patients reverted to episodic headache after 6 months, but the levels of nociceptin and CGRP were unchanged (p=0.71 and p=0.82). Conclusion In contrast to previous findings in migraine patients, we found normal serum levels of nociceptin and CGRP in MOH patients. Thus, we find no evidence that the increased headache frequency of MOH patients could be caused by altered nociceptin and CGRP levels. This underlines the importance of identifying medication overuse in chronic headache and treating the MOH.Keywords
Funding Information
- TrygFonden
This publication has 37 references indexed in Scilit:
- Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugsPharmacology & Therapeutics, 2013
- Drug-dependence behaviour and outcome of medication-overuse headache after treatmentThe Journal of Headache and Pain, 2012
- Treatment‐Resistant Medication Overuse Headache Can Be CuredHeadache: The Journal of Head and Face Pain, 2012
- Pain Processing in Medication Overuse Headache: A Functional Magnetic Resonance Imaging (fMRI) StudyPain Medicine, 2012
- Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal periodThe Journal of Headache and Pain, 2009
- Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteersThe Journal of Headache and Pain, 2009
- Nociceptin (1–13)NH 2 Inhibits Stimulated Calcitonin-Gene-Related-Peptide Release From Primary Cultures of Rat Trigeminal Ganglia NeuronesCephalalgia, 2007
- No increase of calcitonin gene–related peptide in jugular blood during migraineAnnals of Neurology, 2005
- Sumatriptan Causes Parallel Decrease in Plasma Calcitonin Gene-Related Peptide (CGRP) Concentration and Migraine Headache During Nitroglycerin Induced Migraine AttackCephalalgia, 2005
- Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassayPeptides, 1991